1. Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma. (24th January 2013) Authors: Lou, Emil; Peters, Katherine B.; Sumrall, Ashley L.; Desjardins, Annick; Reardon, David A.; Lipp, Eric S.; Herndon, James E.; Coan, April; Bailey, Leighann; Turner, Scott; Friedman, Henry S.; Vredenburgh, James J. Journal: Cancer medicine Issue: Volume 2:Number 2(2013:Apr.) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗